Navigation Links
CosmosID unveils new tool for faster, specific and accurate testing of probiotics products
Date:5/20/2013

Washington, D.C., May 20, 2013 CosmosID, a leading data mining solutions company for health and wellness, has reported as part of a collaboration results on analysis of labeling claims for the composition of probiotic products comparing speed, specificity, and accuracy.

The Food and Drug Administration (FDA) and CosmosID conducted side-by-side analysis of a number of commercially available probiotics, four of which have been reported at the American Society for Microbiology. The purpose of the tests was to compare the identity of species and strains present in the products to what was stated on their respective labels.

An Illumnia MiSeq sequencer was utilized to produce whole genome sequence files of the mixture of bacteria contained in the probiotic. Sequencing produced DNA fragments associated with each strain contained in the sample and was the basis for analyses to determine the amount and type of active ingredients contained in the probiotics. For the side-by-side testing, the FDA used conventional k-mer approach developed in house. CosmosID used its GENIUS product, NmerCE.

Overall, both the FDA's k-mer and CosmosID's NmerCE approaches were able to determine the active ingredients in each probiotic, as well as whether contaminants were present. The advantage of CosmosID's Genius product over the FDA's k-mer counting was both the speed at which the CosmosID's NmerCE was able to complete the analysis, and the ability to provide enhanced specificity in separating different species groups into specific strains.

The results were summarized in an abstract submitted by the FDA at the 133rd General Meeting of the American Society for Microbiology (ASM), which stated "In total, we developed a package of molecular approaches that stratifies genetic depth and regulatory need for appropriate strain identification for voluntary submissions but have widely useful applications from GMP surveillance for unexpected pathogens." Results will be presented May 19 at the ASM Denver meeting.

According to CosmosID's CTO and lead scientist, Dr. Thomas A. Cebula, and Dr. Nur A. Hasan, director, CosmosID Genomics R&D, "Utilization of our algorithms helps remove the computational bottleneck associated with metagenomic analyses, thus facilitating rapid detection, identification, and quantification of microbes in complex samples. As probiotic bacteria are becoming increasingly important in the context of human health, CosmosID GENIUS product will be extremely valuable for the industry in speed of use, quality control, quality assessment, and safety evaluations."

"CosmosID's Genius product will enable manufacturers of probiotics to quickly and accurately validate the labeling of their products for GMP surveillance for unexpected pathogens, or aid in developing and testing new probiotic products," stated CosmosID's chief executive officer, Doug Brenner. "Widespread use of strain-specific analysis of probiotics and their effects on microbial populations will level the playing field in the probiotics industry to assist in documenting efficacy and support labeling claims of companies that conduct rigorous testing against those that choose not to do so."


'/>"/>

Contact: Robin Buckley
robin@buckleykaldenbach.com
703-201-3524
Buckley & Kaldenbach, Inc.
Source:Eurekalert

Related medicine news :

1. IQware Solutions Unveils New Website, New Corporate Identity
2. CustomerCentric Selling® Unveils New Client Testimonial Videos to Showcase Significant Sales Success
3. DRE Medical Equipment Unveils FX-300+ Surgical Headlight and Light Source
4. 'EMT Exam Ace' Unveils Free Sample EMT Practice Quizzes
5. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
6. Naturel Collagen Canada Unveils C RUM, the Newest Addition to the Revolutionary Natural Collagen Skin Care Product Line
7. ShopPharmacyCounter.com Unveils PhenObestin 37.5 to Offset Obesity Effectively
8. Garden Media Unveils 2013-14 Garden Trends: ‘Finding Bliss in the Garden’- Part 3
9. Garden Media Group Unveils New Marketing and Public Relations Blog, GROW
10. Physicians Indemnity Risk Retention Group Unveils New Website
11. Marketing Xocolate International Corporation (MXI Corp) Unveils New Healthy Dark Chocolate Product: Xoçai™ Nuggets, Which Are Both Diabetic And Vegan Friendly
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many ... been diagnosed with endometriosis. These women need a treatment plan to not only ... approach that can help for preservation of fertility and ultimately achieving a pregnancy. ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
(Date:6/25/2016)... ... ... On Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health ... of their exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards ... at the BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to ...
(Date:6/24/2016)... Michigan (PRWEB) , ... June 24, 2016 , ... June ... about the dangers associated with chronic pain and the benefits of holistic treatments, ... individuals who are suffering with Sickle Cell Disease. , Sickle Cell Disease (SCD) is ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 2016 Research and Markets has announced ... Forecast to 2022" report to their offering. ... the patients with kidney failure, it replaces the function of ... patient,s blood and thus the treatment helps to keep the ... balance. Increasing number of ESRD patients & ...
(Date:6/23/2016)... June 23, 2016 Roche (SIX: RO, ROG; ... for its Elecsys BRAHMS PCT (procalcitonin) assay as a ... septic shock. With this clearance, Roche is the first ... integrated solution for sepsis risk assessment and management. ... infection and PCT levels in blood can aid clinicians ...
(Date:6/23/2016)... Bracket , a leading clinical trial technology ... outcomes platform, Bracket eCOA (SM) 6.0, at the 52 ... 30, 2016 in Philadelphia , Pennsylvania.  A ... product of its kind to fully integrate with RTSM, will ... 6.0 is a flexible platform for electronic clinical outcomes assessments ...
Breaking Medicine Technology: